Concepedia

David Wyles

DW

Statistics

Publications

79

Citations

6.5K

H-Index

38

Active since

2004

Affiliations

University of California San Diego(Current)

University of Colorado Denver

Denver Health Medical Center

Gilead Sciences (United States)

Johns Hopkins University

David Wyles is an author at University of California San Diego specializing in viral hepatitis, antiviral therapy, and virology.

ORCID

Publications per year

2004–2025

79

Publications

79

Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

Eric Lawitz, Alessandra Mangia, David Wyles et al. · New England Journal of Medicine · 2013 · 1.8K citations

, , +17

Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1

David Wyles, Peter Ruane, Mark Sulkowski et al. · New England Journal of Medicine · 2015 · 422 citations · Full text

, , +17

Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1

Mark Sulkowski, Joseph J. Eron, David Wyles et al. · JAMA · 2015 · 305 citations · Full text

, , +17

Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1–6 without cirrhosis

Paul Y. Kwo, Fred Poordad, Armen Asatryan et al. · Journal of Hepatology · 2017 · 297 citations · Full text

, , +16

Infrequent Development of Resistance in Genotype 1–6 Hepatitis C Virus–Infected Subjects Treated With Sofosbuvir in Phase 2 and 3 Clinical Trials

Evguenia S. Svarovskaia, Hadas Dvory‐Sobol, Neil Parkin et al. · Clinical Infectious Diseases · 2014 · 216 citations · Full text

, , +17

1–5 of 79